K005043PAnti-FIP1L1 Polyclonal Antibody
- 发布日期: 2020-03-04
- 更新日期: 2026-01-19
产品详请
| 产地 |
北京
|
| 品牌 |
solarbio
|
| 货号 |
K005043P
|
| 保存条件 |
Store at -20°C. Avoid freeze / thaw cycles.
|
| 用途 |
蛋白研究,分析,检测
|
| 应用范围 |
WB IHC IF
|
| 抗原来源 |
|
| CAS编号 |
|
| 保质期 |
|
| 抗体名 |
Anti-FIP1L1 Polyclonal Antibody
|
| 是否单克隆 |
否
|
| 克隆性 |
|
| 靶点 |
FIP1L1
|
| 适应物种 |
Human Mouse Rat
|
| 形态 |
液体
|
| 宿主 |
Rabbit
|
| 标记物 |
|
| 包装规格 |
50ul
|
| 纯度 |
%
|
| 亚型 |
IgG
|
| 标识物 |
|
| 浓度 |
%
|
| 免疫原 |
Recombinant protein of human FIP1L1
|
| 是否进口 |
否
|
背景资料:This gene encodes a subunit of the CPSF (cleavage and polyadenylation specificity factor) complex that polyadenylates the 3' end of mRNA precursors. This gene, the homolog of yeast Fip1 (factor interacting with PAP), binds to U-rich sequences of pre-mRNA and stimulates poly(A) polymerase activity. Its N-terminus contains a PAP-binding site and its C-terminus an RNA-binding domain. An interstitial chromosomal deletion on 4q12 creates an in-frame fusion of human genes FIP1L1 and PDGFRA (platelet-derived growth factor receptor, alpha). The FIP1L1-PDGFRA fusion gene encodes a constitutively activated tyrosine kinase that joins the first 233 amino acids of FIP1L1 to the last 523 amino acids of PDGFRA. This gene fusion and chromosomal deletion is the cause of some forms of idiopathic hypereosinophilic syndrome (HES). This syndrome, recently reclassified as chronic eosinophilic leukemia (CEL), is responsive to treatment with tyrosine kinase inhibitors. Alternative splicing results in multiple transcript variants encoding distinct isoforms.